A carregar...
CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
BACKGROUND: Developing novel strategies to overcome the immunosuppressive tumor microenvironment is a critically important area of cancer therapy research. Here, we assess the therapeutic potential of CD244 (2B4/signaling lymphocyte activation molecule family 4), an immunoregulatory receptor found o...
Na minha lista:
| Publicado no: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7174077/ https://ncbi.nlm.nih.gov/pubmed/32217758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000245 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|